Cargando…
Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre
SIMPLE SUMMARY: Surgical and survival outcomes for uterine corpus cancer following the introduction of robotic surgery to Royal Surrey NHS Foundation Trust; a large volume United Kingdom teaching hospital and cancer centre. Introduction of the Da Vinci(TM) robot was associated with enhanced recovery...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657636/ https://www.ncbi.nlm.nih.gov/pubmed/36358881 http://dx.doi.org/10.3390/cancers14215463 |
_version_ | 1784829746942574592 |
---|---|
author | Uwins, Christina Hablase, Radwa Assalaarachchi, Hasanthi Tailor, Anil Stewart, Alexandra Chatterjee, Jayanta Ellis, Patricia Skene, Simon S. Michael, Agnieszka Butler-Manuel, Simon |
author_facet | Uwins, Christina Hablase, Radwa Assalaarachchi, Hasanthi Tailor, Anil Stewart, Alexandra Chatterjee, Jayanta Ellis, Patricia Skene, Simon S. Michael, Agnieszka Butler-Manuel, Simon |
author_sort | Uwins, Christina |
collection | PubMed |
description | SIMPLE SUMMARY: Surgical and survival outcomes for uterine corpus cancer following the introduction of robotic surgery to Royal Surrey NHS Foundation Trust; a large volume United Kingdom teaching hospital and cancer centre. Introduction of the Da Vinci(TM) robot was associated with enhanced recovery after surgery with low 30-day mortality (0.1%), low return to theatre (0.5%), a low use of blood transfusion and intensive care (1.8% & 7.2% respectively), low conversion to open surgery (0.5%) and a reduction in median length of stay, with comparable survival to published data, and a three to four fold increase in cases treated. This increased productivity was associated with a highly predicable patient pathway of care, for high-risk patients, with reduced demands on health services. ABSTRACT: Royal Surrey NHS Foundation Trust introduced robotic surgery for uterine corpus cancer in 2010 to support increased access to minimally invasive surgery, a central element of an enhanced recovery after surgery (ERAS) pathway. More than 1750 gynaecological oncology robotic procedures have now been performed at Royal Surrey NHS Foundation Trust. A retrospective cohort study was performed of patients undergoing surgery for uterine corpus cancer between the 1 January 2010 and the 31 December 2019 to evaluate its success. Data was extracted from the dedicated gynaecological oncology database and a detailed notes review performed. During this time; 952 patients received primary surgery for uterine corpus cancer; robotic: n = 734; open: n = 164; other minimally invasive surgery: n = 54. The introduction of the Da Vinci(TM) robot to Royal Surrey NHS Foundation Trust was associated with an increase in the minimally invasive surgery rate. Prior to the introduction of robotic surgery in 2008 the minimally invasive surgery (MIS) rate was 33% for women with uterine corpus cancer undergoing full surgical staging. In 2019, 10 years after the start of the robotic surgery program 91.3% of women with uterine corpus cancer received robotic surgery. Overall the MIS rate increased from 33% in 2008 to 92.9% in 2019. Robotic surgery is associated with a low 30-day mortality (0.1%), low return to theatre (0.5%), a low use of blood transfusion and intensive care (1.8% & 7.2% respectively), low conversion to open surgery (0.5%) and a reduction in median length of stay from 6 days (in 2008) to 1 day, regardless of age/BMI. Robotic survival is consistent with published data. Introduction of the robotic program for the treatment of uterine cancer increased productivity and was associated with a highly predicable patient pathway of care, for high-risk patients, with reduced demands on health services. Future health care commissioning should further expand access to robotic surgery nationally for women with uterine corpus cancer. |
format | Online Article Text |
id | pubmed-9657636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96576362022-11-15 Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre Uwins, Christina Hablase, Radwa Assalaarachchi, Hasanthi Tailor, Anil Stewart, Alexandra Chatterjee, Jayanta Ellis, Patricia Skene, Simon S. Michael, Agnieszka Butler-Manuel, Simon Cancers (Basel) Article SIMPLE SUMMARY: Surgical and survival outcomes for uterine corpus cancer following the introduction of robotic surgery to Royal Surrey NHS Foundation Trust; a large volume United Kingdom teaching hospital and cancer centre. Introduction of the Da Vinci(TM) robot was associated with enhanced recovery after surgery with low 30-day mortality (0.1%), low return to theatre (0.5%), a low use of blood transfusion and intensive care (1.8% & 7.2% respectively), low conversion to open surgery (0.5%) and a reduction in median length of stay, with comparable survival to published data, and a three to four fold increase in cases treated. This increased productivity was associated with a highly predicable patient pathway of care, for high-risk patients, with reduced demands on health services. ABSTRACT: Royal Surrey NHS Foundation Trust introduced robotic surgery for uterine corpus cancer in 2010 to support increased access to minimally invasive surgery, a central element of an enhanced recovery after surgery (ERAS) pathway. More than 1750 gynaecological oncology robotic procedures have now been performed at Royal Surrey NHS Foundation Trust. A retrospective cohort study was performed of patients undergoing surgery for uterine corpus cancer between the 1 January 2010 and the 31 December 2019 to evaluate its success. Data was extracted from the dedicated gynaecological oncology database and a detailed notes review performed. During this time; 952 patients received primary surgery for uterine corpus cancer; robotic: n = 734; open: n = 164; other minimally invasive surgery: n = 54. The introduction of the Da Vinci(TM) robot to Royal Surrey NHS Foundation Trust was associated with an increase in the minimally invasive surgery rate. Prior to the introduction of robotic surgery in 2008 the minimally invasive surgery (MIS) rate was 33% for women with uterine corpus cancer undergoing full surgical staging. In 2019, 10 years after the start of the robotic surgery program 91.3% of women with uterine corpus cancer received robotic surgery. Overall the MIS rate increased from 33% in 2008 to 92.9% in 2019. Robotic surgery is associated with a low 30-day mortality (0.1%), low return to theatre (0.5%), a low use of blood transfusion and intensive care (1.8% & 7.2% respectively), low conversion to open surgery (0.5%) and a reduction in median length of stay from 6 days (in 2008) to 1 day, regardless of age/BMI. Robotic survival is consistent with published data. Introduction of the robotic program for the treatment of uterine cancer increased productivity and was associated with a highly predicable patient pathway of care, for high-risk patients, with reduced demands on health services. Future health care commissioning should further expand access to robotic surgery nationally for women with uterine corpus cancer. MDPI 2022-11-07 /pmc/articles/PMC9657636/ /pubmed/36358881 http://dx.doi.org/10.3390/cancers14215463 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Uwins, Christina Hablase, Radwa Assalaarachchi, Hasanthi Tailor, Anil Stewart, Alexandra Chatterjee, Jayanta Ellis, Patricia Skene, Simon S. Michael, Agnieszka Butler-Manuel, Simon Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre |
title | Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre |
title_full | Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre |
title_fullStr | Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre |
title_full_unstemmed | Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre |
title_short | Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre |
title_sort | enhanced recovery after uterine corpus cancer surgery: a 10 year retrospective cohort study of robotic surgery in an nhs cancer centre |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657636/ https://www.ncbi.nlm.nih.gov/pubmed/36358881 http://dx.doi.org/10.3390/cancers14215463 |
work_keys_str_mv | AT uwinschristina enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT hablaseradwa enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT assalaarachchihasanthi enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT tailoranil enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT stewartalexandra enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT chatterjeejayanta enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT ellispatricia enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT skenesimons enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT michaelagnieszka enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre AT butlermanuelsimon enhancedrecoveryafteruterinecorpuscancersurgerya10yearretrospectivecohortstudyofroboticsurgeryinannhscancercentre |